Despite positive news of vaccines, screening is still necessary to control the pandemic. Our breath test system will provide rapid, non-invasive and affordable solution for mass screening. Initial clinical trials with National Centre for Infectious Diseases (NCID) of Singapore has shown promising results of over 90% accuracy. We currently have ongoing extended trials (locally and overseas) to further improve our accuracy and are seeking regulatory approval. We are developing our technology to detect a wide range of diseases namely Lung Cancer, Nasopharyngeal Cancer and Tuberculosis. We are developing our breath test solution to become more portable and affordable for everyone.